Nephron Launches New Syringe Presentation
Retrieved on:
Monday, January 31, 2022
WEST COLUMBIA, S.C., Jan. 31, 2022 /PRNewswire/ -- Continuing to build on the momentum that comes with explosive growth, Nephron Pharmaceuticals Corporation today announced the launch of a brand new syringe presentation under the highly successful Nephron 503B Outsourcing Facility operation.
Key Points:
- WEST COLUMBIA, S.C., Jan. 31, 2022 /PRNewswire/ -- Continuing to build on the momentum that comes with explosive growth, Nephron Pharmaceuticals Corporation today announced the launch of a brand new syringe presentation under the highly successful Nephron 503B Outsourcing Facility operation.
- Nephron Launches New Syringe Presentation.
- 8.4% Sodium Bicarbonate Injection is the first product Nephron is set to launch in a COC syringe.
- In July, Nephron announced the opening of Nephron Nitrile, a plant that will produce American-made, medical-grade nitrile gloves.